Hester Biosciences Ltd
₹2,264.90
-0.62%
Delayed · cached 15 min
Fair value analysis
HESTERBIO
Hester Biosciences Ltd
₹2,279.00
Close used for this calculation
₹1,690.18Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
55/100
Quality radar
Consensus fair value
₹1,690.18
Above FV▼ -25.8% against the close used
Model range ₹773.22 – ₹2,945.79
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹773.22Fair value₹1,690.18Bull₹2,945.79
FairClose
52-week traded range
52W low ₹1,259.1052W high ₹2,545.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Hester Biosciences Ltd closed at ₹2,279.00, 34.8% above the consensus fair value of ₹1,690.18 drawn from 9 valuation models.
Financial DNA score 55/100 — Good. P/E of 36.3x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹1,103.31
-51.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹773.22
-66.1%
√(22.5 × EPS × BVPS)
EPS=65.41, BVPS=406.24 · outside Graham range (P/E 36.3, P/B 5.6) — asset-light, treat as a rough floor
Graham Formula
₹2,945.79
+29.3%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=20%, FD=7%
P/E Fair Value
₹2,335.14
+2.5%
EPS × 35.7x (sector P/E)
EPS=65.41, Sector P/E=35.7x
Peter Lynch (PEG)
₹1,635.25
-28.2%
EPS × Growth% (PEG = 1 is fair)
EPS=65.41, g=25%
EV/EBITDA
₹2,025.91
-11.1%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=1.06B
Book Value (P/B)
₹1,005.44
-55.9%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=406.24, ROE=15.9%, g=6%, r=10%
Reverse DCF
₹2,279.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 14.6% | Historical: 25%
Margin of Safety
₹1,342.02
-41.1%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=1789.36, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.